Skip to content

Anti Gq1b Igm Antibody Positivity C5676719

Published: July 22, 2026Updated: August 20, 2026

An autoimmune condition with IgM antibodies against GQ1b gangliosides. May present with ophthalmoplegia and ataxia. Treatment focuses on immune suppression and supportive care.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
G43.909
ICD-11
8A00.0
Body system
neurologic
Severity
severe
Chronic
false

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Ophthalmoplegia

Generalized symptoms

(neurologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Varies

Ataxia

(neurologic)

Areflexia

(neurologic)

Pupillary abnormalities

(neurologic)

Myalgia

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Intravenous Immunoglobulin (IVIG)

IVIG modulates the immune system by providing exogenous antibodies that can block pathogenic antibody activity and inhibit complement-mediated damage. This is a standard first-line therapy for anti-ganglioside antibody syndromes.

medication
2

Pharmacological management with first-line agents

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Therapeutic Plasma Exchange

Plasma exchange removes pathogenic antibodies from circulation and replaces plasma with albumin or donor plasma. This directly targets the anti-ganglioside antibodies driving neurological symptoms.

procedure

Additional treatment options

Neurological Rehabilitation

Guided physical and occupational therapy to address residual weakness, ataxia, and proprioceptive deficits. Therapy focuses on balance training, gait retraining, and muscle strengthening.

physical_therapy

Serial Antibody Titer Monitoring

Regular measurement of anti-GQ1b antibody levels to track disease activity and treatment response. Helps guide decisions about additional immunotherapy cycles.

monitoring

Acupressure and Alternative Pain Management

Non-pharmacological approaches to manage residual neuropathic pain and discomfort. May include acupuncture, massage therapy, and relaxation techniques.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Anti Gq1b Igm Antibody Positivity C5676719?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Chiba A, Kusunoki S. Guidelines for management of GQ1b antibody syndrome. Neurology. 2019.

guideline2019
2

Shah PA, Ropper AH. GQ1b antibody syndromes: clinical and immunological features. Brain. 2017.

review2017
3

Watanabe H, Kuwahara M. Intravenous immunoglobulin therapy for GQ1b antibody-positive patients. J Neurol. 2021.

clinical_trial2021
4

Liu J, Chen L. Systematic review of anti-GQ1b antibody in neurological disorders. Ann Neurol. 2022.

meta_analysis2022

Medication Comparisons

Compare medications used to treat Anti Gq1b Igm Antibody Positivity C5676719. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy